Introduction: Glycosphingolipids in cell biology and disease

Seminars in Cell and Developmental Biology

Volumn 15, Issue 4, 2004, Pages 371-373

  Sillence, Dan J ^a   Platt, Fran M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLYCOSPHINGOLIPID; SPHINGOSINE;

CELL MEMBRANE; CYTOLOGY; EDITORIAL; ENDOCYTOSIS; GENETIC DISORDER; NONHUMAN; PROTEIN DOMAIN;

EID: 2942679133     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2004.03.008     Document Type: Editorial

References (25)

1. Venkataraman K., Riebeling C., Bodennec J., et al. Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N- stearoyl-sphinganine (C18-(dihydro) ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J. Biol. Chem. 277:2002;35642-35649
2. De Rosa M.F., Sillence D., Ackerley C., Lingwood C. Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. J. Biol. Chem. 279:2004;7867-7876
3. Lala P., Ito S., Lingwood C.A. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p- glycoprotein in glycolipid synthesis. J. Biol. Chem. 275:2000;6246-6251
4. Riebeling C., Allegood J.C., Wang E., Merrill A.H. Jr., Futerman A.H. Two Mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-coa donors. J. Biol. Chem. 278:2003;43452-43459
5. Colsch B., Afonso C., Popa I., et al. Characterization of the ceramide moieties of sphingoglycolipids from mouse brain by ESI-MS/MS: identification of ceramides containing sphingadienine. J. Lipid Res. 45:2004;281-286
6. Gillard B.K., Clement R.G., Marcus D.M. Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways. Glycobiology. 8:1998;885-890
7. Warnock D.E., Lutz M.S., Blackburn W.A., Young W.W., Baenziger J.U. Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2708-2712
8. Sasaki T., Abe A. Glycolipid transfer protein from pig brain. Methods Enzymol. 179:1989;559-566
9. Hanada K., Kumagai K., Yasuda S., et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 426:2003;803-809
10. Yamashita T., Wada R., Sasaki T., et al. A vital role for glycosphingolipid synthesis during development and differentiation. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9142-9147
11. Li C.M., Park J.H., Simonaro C.M., et al. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes. Genomics. 79:2002;218-224
12. Simons K., van Meer G. Lipid sorting in epithelial cells. Biochemistry. 27:1988;6197-6202
13. Schutz G.J., Kada G., Pastushenko V.P., Schindler H. Properties of lipid microdomains in a muscle cell membrane visualized by single molecule microscopy. EMBO J. 19:2000;892-901
14. Sharma P., Varma R., Sarasij R.C., et al. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell. 116:2004;577-589
15. Munro S. Lipid rafts: elusive or illusive? Cell. 115:2003;377-388
16. Singh R.D., Puri V., Valiyaveettil J.T., Marks D.L., Bittman R., Pagano R.E. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol. Biol. Cell. 14:2003;3254-3265
17. Sharma D.K., Choudhury A., Singh R.D., Wheatley C.L., Marks D.L., Pagano R.E. Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. J. Biol. Chem. 278:2003;7564-7572
18. Gravel RA, Clarke JTR, Kaback MM, Mahuran D, Sandhoff K, Suzuki K. The GM2 gangliosidoses. In: Scriver CR, Beadet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw Hill, 1995:2839-79.
19. Simons K., Gruenberg J. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol. 10:2000;459-462
20. Pagano R.E., Puri V., Doniguez M., Marks D.L. Membrane traffic in sphingolipid storage disease. Traffic. 1:2000;807-815
21. Choudhury A., Dominguez M., Puri V., et al. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109:2002;1541-1550
22. Mayran N., Parton R.G., Gruenberg J. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J. 22:2003;3242-3253
23. te Vruchte D, Lloyd-Evans E, Veldman RJ, et al. The accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endocytic transport. J Biol Chem [in press]. http://www.jbc.org/cgi/reprint/m31159I200v1.
24. Puri V., Watanabe R., Dominguez M., et al. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat. Cell Biol. 1:1999;386-388
25. Sillence D.J., Puri V., Marks D.L., et al. Glucosylceramide modulates membrane traffic along the endocytic pathway. J. Lipid Res. 43:2002;1837-1845